X4 Pharmaceuticals logo

X4 Pharmaceuticals Share Price (NASDAQ: XFOR)

$4.3

0.07

(1.65%)

Live

Last updated on

Check the interactive X4 Pharmaceuticals Stock chart to analyse performance

X4 Pharmaceuticals stock performance

as on August 28, 2025 at 11:38 pm IST

  • Today's Low:$4.26
    Today's High:$4.32

    Day's Volatility :1.39%

  • 52 Weeks Low:$1.35
    52 Weeks High:$26.83

    52 Weeks Volatility :94.97%

X4 Pharmaceuticals Stock Returns

PeriodX4 Pharmaceuticals IncIndex (Russel 2000)
3 Months
20.17%
0.0%
6 Months
-61.84%
0.0%
1 Year
-79.57%
0.0%
3 Years
-85.31%
-6.9%

X4 Pharmaceuticals Inc Key Stats

Check X4 Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.23
Open
$4.575
Today's High
$4.32
Today's Low
$4.03
Market Capitalization
$102.8M
Today's Volume
$1.4M
52 Week High
$26.829
52 Week Low
$1.35
Revenue TTM
$32.8M
EBITDA
$-104.5M
Earnings Per Share (EPS)
$-15.14
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-207.22%

Stock Returns calculator for X4 Pharmaceuticals Stock including INR - Dollar returns

The X4 Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

X4 Pharmaceuticals investment value today

Current value as on today

₹25,133

Returns

₹74,867

(-74.87%)

Returns from X4 Pharmaceuticals Stock

₹79,227 (-79.23%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards X4 Pharmaceuticals Stock

210.53%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Investment in X4 Pharmaceuticals Shares from India has grown by 210.53% over the past 30 days, indicating increased transactional activity.

201%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for X4 Pharmaceuticals Stock from India on INDmoney has increased by 201% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in X4 Pharmaceuticals Inc

  • Name

    Holdings %

  • Bain Capital Life Sciences Investors, LLC

    7.08%

  • Kingdon Capital Management LLC

    2.93%

  • Vanguard Group Inc

    2.91%

  • Pale Fire Capital SE

    0.75%

  • Squarepoint Ops LLC

    0.49%

  • AQR Capital Management LLC

    0.33%

Analyst Recommendation on X4 Pharmaceuticals Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for X4 Pharmaceuticals(by analysts ranked 0 to 5 stars)

X4 Pharmaceuticals Share Price Target

What analysts predicted

Upside of 440.7%

Target:

$23.25

Current:

$4.30

X4 Pharmaceuticals share price target is $23.25, a slight Upside of 440.7% compared to current price of $4.30 as per analysts' prediction.

X4 Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, XFOR stock has moved up by 33.0%
  • XFOR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 141.4%
  • XFOR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 201.9%
  • Price to Sales

    ForXFOR every $1 of sales, investors are willing to pay $0.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

X4 Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

X4 Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

X4 Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
X4 Pharmaceuticals Inc logo
119.74%
-61.84%
-79.57%
-85.31%
-98.32%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About X4 Pharmaceuticals Inc

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally bioavailable selective antagonist of chemokine receptor C-X-C chemokine receptor type 4 (CXCR4) for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. The company also develops mavorixafor that is in Phase 3 4WARD clinical trial to evaluate the efficacy, safety, and tolerability of oral, once-daily mavorixafor with or without stable doses of G-CSF in people with congenital, acquired primary autoimmune, or idiopathic CN who are experiencing recurrent and/or serious infections. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications; and with Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand. The company is headquartered in Boston, Massachusetts.
Organization
X4 Pharmaceuticals
Employees
143
CEO
Mr. Mark Baldry M.B.A.
Industry
Biotechnology

Key Management of X4 Pharmaceuticals Inc

NameTitle
Mr. Mark Baldry M.B.A.
Chief Commercial Officer
Dr. Adam R. Craig M.B.A., M.D., Ph.D.
Executive Chair
Mr. John P. Volpone
President
Dr. Richard Peters M.D., Ph.D.
Founder
Dr. Renato T. Skerlj Ph.D.
Founder
Dr. Keith T. Flaherty M.D.
Founder & Member of Corporate Advisory Board
Mr. David H. Kirske
Chief Financial Officer
Dr. Mary DiBiase Ph.D.
Chief Operating Officer
Ms. Natasha Thoren Esq.
Chief Legal & Compliance Officer
Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in XFOR Stock from India :

What is X4 Pharmaceuticals share price today?

X4 Pharmaceuticals share price today is $4.30 as on . X4 Pharmaceuticals share today touched a day high of $4.32 and a low of $4.26.

What is the 52 week high and 52 week low for X4 Pharmaceuticals share?

X4 Pharmaceuticals share touched a 52 week high of $26.83 and a 52 week low of $1.35. X4 Pharmaceuticals stock price today i.e. is trending at $4.30, lower by 83.97% versus the 52 week high.

How to invest in X4 Pharmaceuticals Stock (XFOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for X4 Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in X4 Pharmaceuticals Shares that will get you 0.3488 shares as per X4 Pharmaceuticals share price of $4.30 per share as on August 28, 2025 at 11:38 pm IST.

What is the minimum amount required to buy X4 Pharmaceuticals Stock (XFOR) from India?

Indian investors can start investing in X4 Pharmaceuticals (XFOR) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in X4 Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on X4 Pharmaceuticals share’s latest price of $4.30 as on August 28, 2025 at 11:38 pm IST, you will get 2.3256 shares of X4 Pharmaceuticals. Learn more about fractional shares .

What are the returns that X4 Pharmaceuticals has given to Indian investors in the last 5 years?

X4 Pharmaceuticals stock has given -98.32% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?